Expert Insights on Food and Drug Administration (FDA)

The Food and Drug Administration (FDA) is a U.S. government agency tasked with ensuring that no adulterated or misbranded foods, drugs, or medical devices enter interstate commerce. It also oversees dietary supplements, biological medical products, blood products, medical devices, radiation-emitting devices, veterinary products, and cosmetics. It is also the agency that governs clinical trials of medications.

Gerson Lehrman Group Council Members are available to discuss Food and Drug Administration (FDA) via phone consultations, live meetings, surveys, and other custom GLG products and services.

Find, engage, and manageSM experts today through the GLG platform

Featured Council Members

GLG Council Members are leading experts including academics, scientists, and industry specialists

John Kamp, Of Counsel, WILEY REIN LLP

John KampWhat is a GLG Educator?|GLG Educators have qualified for GLG Member Programs and are therefore eligible to participate in ongoing in-depth consulting projects with GLG clients.

Of CounselWILEY REIN LLP

Jim Farley, President, Cardinal Consulting and Training

Jim Farley
          What is a GLG Leader?|The Gerson Lehrman Group&reg; (GLG) Leader Program<sup>SM</sup> is our premium Member Program<sup>SM</sup>. Those identified as GLG Leaders are in the top 5% of GLG CouncilRank and have an exclusivity agreement with GLG.

PresidentCardinal Consulting and Training

Gregory Glover, Partner, Pharmaceutical Law Group PC

Gregory GloverWhat is a GLG Educator?|GLG Educators have qualified for GLG Member Programs and are therefore eligible to participate in ongoing in-depth consulting projects with GLG clients.

PartnerPharmaceutical Law Group PC

John Kamp, Of Counsel, WILEY REIN LLP

John KampWhat is a GLG Educator?|GLG Educators have qualified for GLG Member Programs and are therefore eligible to participate in ongoing in-depth consulting projects with GLG clients.

Of CounselWILEY REIN LLP

Jim Farley, President, Cardinal Consulting and Training

Jim Farley
          What is a GLG Leader?|The Gerson Lehrman Group&reg; (GLG) Leader Program<sup>SM</sup> is our premium Member Program<sup>SM</sup>. Those identified as GLG Leaders are in the top 5% of GLG CouncilRank and have an exclusivity agreement with GLG.

PresidentCardinal Consulting and Training

Browse all 298 Leading Experts

Recent News Analyses

News analyses are expert commentaries on current events, written by Council Members who are available for follow up consultations

IOM Report on the FDA 510k process

August 5, 2011

Mac McKeen, Faculty Director, College of Continuing Education, UNIVERSITY OF MINNESOTA

FDA Approves Oxecta – PDUFA for Remoxy Due 6/23/11

June 20, 2011

FDA Panel Denies Gout Drug Ilaris (Novartis) ? Concern for Regeneron’s Arcalyst

June 22, 2011

Federal Pre-emption of Pharmaceuticals and Medical Devices: A Murky Landscape

August 4, 2011

Browse all 1772 GLG News Analyses

Contact Gerson Lehrman Group to engage a Food and Drug Administration (FDA) expert